FDA Called Two Sentences on a Ketamine Booth Extremely Concerning
FDA cited Alar Pharmaceuticals over claims for an investigational ketamine product. The flagged phrases show up in a lot of clinic marketing.
Read Morelisteo-data-scraper domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/healingmaps.imarkdev.com/wp-includes/functions.php on line 6170
FDA cited Alar Pharmaceuticals over claims for an investigational ketamine product. The flagged phrases show up in a lot of clinic marketing.
Read More
A Winston-Salem clinic tracked 92 fibromyalgia patients on high dose ketamine for two years. The dosing model looks nothing like standard practice.
Read More
A new Canadian Journal of Psychiatry paper argues leaner psychedelic protocols displace integration work onto patients’ families. HealingMaps survey data shows those households split evenly.
Read More
SAMHSA told states to build the budget, licensing, and oversight machinery for psychedelic therapy before the FDA approves anything. Ketamine is not named once.
Read More
A Toronto trial paired ketamine with structured therapy for chronic nerve pain. It used three infusions over twelve weeks, not six over three.
Read More
Most of Tacoma’s ketamine infrastructure sits on a single street: the region’s most experienced infusion practice and its widest-menu interventional psychiatry clinic both operate on South Union Avenue, four blocks apart. The four providers ranked here hold verified listings in the HealingMaps Washington directory, and that per-clinic detail drives the rankings; the pricing context around […]
Read More
A ketamine patient in Provo is choosing among three care models more than among neighborhoods: a national interventional psychiatry office downtown, homegrown Utah County programs built around ketamine-assisted psychotherapy, and a flat-rate infusion clinic thirty minutes up I-15. Every provider ranked below is documented in a verified HealingMaps directory listing, while the surrounding cost context […]
Read More
Last reviewed and updated: August 13, 2026. Headlines about the FDA and ketamine will multiply this year. Most operators will read them wrong. Some describe a generic manufacturing application. One concerns NRX-100, a specific IV ketamine product pursuing a psychiatric indication. That program could change how clinics approach coverage, marketing and protocols. Knowing which is […]
Read More
In one Manchester treatment cohort, 64 percent of the people being treated for ketamine problems were under 18. Forty two percent were between 13 and 16. That is what a recreational ketamine crisis looks like once it has fully arrived, and England is living in one. America is not, and the reason has less to […]
Read More
A randomized trial found higher morning cortisol 24 hours after ketamine. Bigger rises tracked with less suicidal thinking, though more data needed.
Read More